Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Targeting ERO1α triggers tumor immunosurveillance in triple-negative breast cancer
Alessandro Cherubini; Ersilia Varone; Sara Irene Malandrin; Alice Marrazza; Giorgia Maria Renna; Serena Germani; Stefano Fumagalli; Angela Bachi; Angela Cattaneo; Michele Retini; Giovanni Piersanti; Marco Bolis; Ilaria Craparotta; Arianna Vallerga; Chiara Grasselli; Manuela Milani; Daniele Generali; Augusto Bleve; Ester ZitoShow moreShow less
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Cogentech SRL Benefit Corporation, Milan, 20139, Italy; Bioinformatics Core Unit, Institute of Oncology Research (IOR), Bellinzona, Switzerland; U.O. Patologia Mammaria e Tumori Cerebrali, Azienda Socio-Sanitaria Territoriale, Cremona, Italy; IRCCS Humanitas Research Hospital, Milan, ItalyShow moreShow less
eNOS uncoupling drives oxidative stress and arrhythmogenic vulnerability in experimental hypothyroidism
Diego Santos Souza; Leisiane Pereira Marques; Aimée Obolari Durço; Fabiana da Silva Alcântara; Diego José Belato Orts; Melissa Tainan Silva Dias; Michael Ramon de Lima Conceiçao; Jorge Lucas Teixeira-Fonseca; Luiz Fernando Santos Matos; Maria Luiza Alarcon Mady Barbosa; Daiara Custódio Santos; Luciano dos Santos Aggum Capettini; Carlos Roberto Prudencio; Danilo Lustrino; Jader Santos Cruz; Danilo Roman-CamposShow moreShow less
Department of Physiology, Federal University of Sergipe, São Cristóvão, Brazil; Department of Biophysics, Federal University of São Paulo, São Paulo, Brazil; Department of Pharmacology, Federal University of Minas Gerais, Belo Horizonte, Brazil; Immunology Center, Institute Adolfo Lutz, São Paulo, Brazil; Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, BrazilShow moreShow less
LncRNA CCDC152 coordinates a tumor-associated selenoprotein P cycle that sustains selenium-dependent redox homeostasis in glioblastoma
Stephanie Siu; Hiroki Taguchi; Xi Zheng; Hikari Sugiura; Shota Yamashita; Tatsuya Takahashi; Masato Kosuge; Takayuki Kaneko; Misaki Shimizu; Yoshiteru Shimoda; Kota Noritsugu; Kotoko Arisawa; Mika Watanabe; Takashi Toyama; Masayuki Kanamori; Hidenori Endo; Yoshiro SaitoShow moreShow less
Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi, 980-8578, Japan; Department of Neurosurgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryo Aoba-ku, Sendai, 980-8574, Japan; Department of Pathology, Tohoku Kosai Hospital, 2-3-11 Kokubuncho, Aoba-ku, Sendai, Miyagi, 980-0803, JapanShow moreShow less
A novel hydrogen persulfide donor HPD1 alleviated LPS-induced neuroinflammation by modulating glial polarization through TLR4-MAPK/NF-κB pathway
Fei Yan; Shouwei Tao; Yan Jiao; Ting Kang; Shuangqing Du; Yue Cheng; Zhenbo Huang; Ping Feng; Bowen KeShow moreShow less
Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, Hainan, 570228, ChinaShow moreShow less
Systematic validation of BACH1 antibodies enables the identification of BACH1 localisation as predictor of prognosis in early-stage lung cancer
Yumna Sharaf; Donika Klenja-Skudrinja; Maureen Higgins; Susan Bray; David Walker; Hazem Abdullah; In Hwa Um; Aileen Sandilands; Neil Kernohan; Albena T. Dinkova-Kostova; David J. Harrison; Laureano de la VegaShow moreShow less
Jacqui Wood Cancer Centre, Division of Cancer Research, School of Medicine, University of Dundee, UK; School of Medicine, University of Dundee, UK; School of Medicine, University of St Andrews, UK; NHS, Ninewells Hospital, Dundee, UKShow moreShow less
HnRNPK suppresses macrophage-driven inflammation in autoimmune myocarditis by restraining NCF1-dependent oxidized phospholipid signaling and ferroptosis-related changes
Han Li; Wenhu Liu; Jing Hu; Jingjie Xiong; Xuehua Wang; Jiaxi Lv; Ni Xiong; Yanling Huang; Qianyi Liu; Lihui Yin; Yan Wang; Ya Wang; Zhaohui WangShow moreShow less
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; Department of Cardiology, Institute of Cardiovascular Diseases, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaShow moreShow less
FAQ
How long does Redox Biology take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Redox Biology. The fastest paper went from submission to acceptance in 3 days (Inhibition of 3-mercaptopyruvate sulfurtransferase enhances CD8+ T-cell antitumor immunity, received 2026-08-23, accepted 2026-08-26); the slowest took 92 days. The average is 39.2 days and the median is 36 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
